(Q80026035)
Statements
Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate (English)
Brian L Swick
Larisa Ravdel
James E Fitzpatrick
William A Robinson